Financials High Tide Inc. Deutsche Boerse AG

Equities

2LYA

CA42981E4013

Drug Retailers

Real-time Estimate Tradegate 14:28:24 17/07/2024 BST 5-day change 1st Jan Change
1.797 EUR +0.39% Intraday chart for High Tide Inc. -4.95% +20.98%

Valuation

Fiscal Period: Oktober 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 51.85 40.5 365.3 139.2 149.8 214 - -
Enterprise Value (EV) 1 51.85 93.59 398.6 183.8 193.6 202 185 214
P/E ratio - -5.67 x -8 x -1.74 x -3.75 x -19.7 x 29.6 x 11.6 x
Yield - - - - - - - -
Capitalization / Revenue 1.66 x 0.49 x 2.02 x 0.39 x 0.31 x 0.42 x 0.36 x 0.31 x
EV / Revenue 1.66 x 1.12 x 2.2 x 0.52 x 0.4 x 0.4 x 0.31 x 0.31 x
EV / EBITDA -3.25 x 11.7 x 32.1 x 12.6 x 6.32 x 5.29 x 4.02 x 2.75 x
EV / FCF -2.34 x 24.3 x -29.8 x -56.4 x 50.8 x 12.6 x 8.68 x -
FCF Yield -42.7% 4.11% -3.36% -1.77% 1.97% 7.92% 11.5% -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 13,827 15,882 54,360 70,297 75,275 80,446 - -
Reference price 2 3.750 2.550 6.720 1.980 1.990 2.660 2.660 2.660
Announcement Date 28/02/20 01/03/21 27/01/22 30/01/23 29/01/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Oktober 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 31.29 83.26 181.1 356.9 487.7 511.1 587.7 698.6
EBITDA 1 -15.94 7.974 12.4 14.62 30.64 38.2 46 77.8
EBIT 1 -19.87 0.796 -18.67 -72.31 -41.42 -5.568 19.15 -
Operating Margin -63.51% 0.96% -10.31% -20.26% -8.49% -1.09% 3.26% -
Earnings before Tax (EBT) 1 - - -35.77 -73.76 -48.6 -21.76 6.2 -
Net income 1 - -6.354 -35.04 -71.76 -39.31 -9.886 7.067 -
Net margin - -7.63% -19.35% -20.11% -8.06% -1.93% 1.2% -
EPS 2 - -0.4500 -0.8400 -1.140 -0.5300 -0.1350 0.0900 0.2300
Free Cash Flow 1 -22.16 3.847 -13.39 -3.26 3.81 16 21.3 -
FCF margin -70.82% 4.62% -7.39% -0.91% 0.78% 3.13% 3.62% -
FCF Conversion (EBITDA) - 48.24% - - 12.44% 41.88% 46.3% -
FCF Conversion (Net income) - - - - - - 301.41% -
Dividend per Share - - - - - - - -
Announcement Date 28/02/20 01/03/21 27/01/22 30/01/23 29/01/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: October 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 72.22 81.03 95.35 108.2 118.1 118.1 124.4 127.1 128.1 124.3 127.2 131.6 137.6 139.4 148.2
EBITDA 1 2.955 2.402 4.246 5.018 5.5 6.589 10.18 8.362 10.44 10.04 8.8 8.9 11.15 11.9 13.4
EBIT 1 -6.147 -7.578 -4.67 -53.92 -3.922 -2.642 -0.662 -34.2 2.792 1.987 2.7 3.1 3.5 4.3 4.9
Operating Margin -8.51% -9.35% -4.9% -49.81% -3.32% -2.24% -0.53% -26.91% 2.18% 1.6% 2.12% 2.36% 2.54% 3.08% 3.31%
Earnings before Tax (EBT) 1 -8.416 -9.077 -1.986 -54.28 -5.098 -3.609 -3.37 -36.38 -0.238 -0.707 -0.3 0.1 0.4 1.3 1.9
Net income 1 -7.352 -8.277 -2.717 -53.41 -3.944 -1.544 -3.574 -30.79 -0.34 -0.025 0.3 0.5 0.3 0.9 1.3
Net margin -10.18% -10.21% -2.85% -49.34% -3.34% -1.31% -2.87% -24.22% -0.27% -0.02% 0.24% 0.38% 0.22% 0.65% 0.88%
EPS 2 -0.1400 -0.1400 -0.0400 -0.8500 -0.0500 -0.0200 -0.0400 -0.3900 -0.004350 - -0.0133 -0.003330 - 0.0100 0.0200
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 17/03/22 14/06/22 14/09/22 30/01/23 17/03/23 14/06/23 14/09/23 29/01/24 15/03/24 13/06/24 - - - - -
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: October 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 53.1 33.3 44.6 43.8 - - -
Net Cash position 1 - - - - - 12 29 -
Leverage (Debt/EBITDA) - 6.658 x 2.689 x 3.051 x 1.429 x - - -
Free Cash Flow 1 -22.2 3.85 -13.4 -3.26 3.81 16 21.3 -
ROE (net income / shareholders' equity) - -59.8% -23.5% -45.1% -7.26% - - -
ROA (Net income/ Total Assets) - -10.7% -11.7% -4.83% -4.11% - - -
Assets 1 - 59.5 299.6 1,486 955.6 - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 8.07 5 10.6 7.76 5.79 12.9 10.2 -
Capex / Sales 25.8% 6.01% 5.83% 2.17% 1.19% 2.52% 1.74% -
Announcement Date 28/02/20 01/03/21 27/01/22 30/01/23 29/01/24 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
2.66 CAD
Average target price
6.1 CAD
Spread / Average Target
+129.32%
Consensus